Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of tumor microenvironment in glioblastoma multiforme identifies ITGB2 as a key immune and stromal related regulator in glial cell types. | Comput Biol Med | 2023 | 37660569 | PubTator, text mining | PubMed |
| Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML. | Front Immunol | 2023 | 37654497 | PubTator, text mining | PubMed |
| Cuproptosis-related prognostic signatures predict the prognosis and immunotherapy in HCC patients. | Medicine (Baltimore) | 2023 | 37653738 | PubTator, text mining | PubMed |
| CD64 as novel molecular imaging marker for the characterization of synovitis in rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37653557 | PubTator, text mining | PubMed |
| An endoplasmic reticulum stress-related signature could robustly predict prognosis and closely associate with response to immunotherapy in pancreatic ductal adenocarcinoma. | J Cancer Res Clin Oncol | 2023 | 37653101 | PubTator, text mining | PubMed |
| Histone deacetylase-mediated tumor microenvironment characteristics and synergistic immunotherapy in gastric cancer. | Theranostics | 2023 | 37649598 | PubTator, text mining | PubMed |
| Combining bulk and single-cell RNA-sequencing data to develop an NK cell-related prognostic signature for hepatocellular carcinoma based on an integrated machine learning framework. | Eur J Med Res | 2023 | 37649103 | PubTator, text mining | PubMed |
| Sequential Exposure to IL21 and IL15 During Human Natural Killer Cell Expansion Optimizes Yield and Function. | Cancer Immunol Res | 2023 | 37649085 | PubTator, text mining | PubMed |
| Identifying prognostic markers in spatially heterogeneous breast cancer microenvironment. | J Transl Med | 2023 | 37644433 | PubTator, text mining | PubMed |
| Single-cell RNA-seq analysis reveals that immune cells induce human nucleus pulposus ossification and degeneration. | Front Immunol | 2023 | 37638033 | PubTator, text mining | PubMed |
| Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective. | Viruses | 2023 | 37631987 | PubTator, text mining | PubMed |
| Circulating Biomarkers Associated with the Diagnosis and Prognosis of B-Cell Progenitor Acute Lymphoblastic Leukemia. | Cancers (Basel) | 2023 | 37627214 | PubTator, text mining | PubMed |
| Sex disparities in non-small cell lung cancer: mechanistic insights from a cRaf transgenic disease model. | EBioMedicine | 2023 | 37625265 | PubTator, text mining | PubMed |
| Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy. | Discov Oncol | 2023 | 37624511 | PubTator, text mining | PubMed |
| CCDC43 as a potential therapeutic target of Tian Yang Wan for the treatment of hepatocellular carcinoma by activating the hippo pathway. | Front Oncol | 2023 | 37614502 | PubTator, text mining | PubMed |
| Red blood cells: a potential delivery system. | J Nanobiotechnology | 2023 | 37608283 | PubTator, text mining | PubMed |
| Current approaches to develop "off-the-shelf" chimeric antigen receptor (CAR)-T cells for cancer treatment: a systematic review. | Exp Hematol Oncol | 2023 | 37605218 | PubTator, text mining | PubMed |
| Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer. | Sci Rep | 2023 | 37604837 | PubTator, text mining | PubMed |
The implication of necroptosis-related lncRNAs in orchestrating immune infiltration and predicting therapeutic efficacy in colon adenocarcinoma: an integrated bioinformatic analysis with preliminarily experimental validation. | Front Genet | 2023 | 37600653 | PubTator, text mining | PubMed |
| Comprehensive characterization of pyroptosis phenotypes with distinct tumor immune profiles in gastric cancer to aid immunotherapy. | Aging (Albany NY) | 2023 | 37595258 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=18